Search results
17 cze 2022 · It is hoped the tablet will halt or slow the progression of Stargardt, one of the most common forms of inherited macular disease, which there is currently no treatment for. Belite Bio said the new drug prevents the build-up of toxins in the eye that cause Stargardt disease.
- Research trial continues into potential treatment for Stargardt
Professor Andrew Lotery has provided an update on the latest...
- Research trial continues into potential treatment for Stargardt
9 lis 2023 · The drug is the first and only medicine to treat Stargardt disease by targeting the underlying causes of the disease and reducing the rate of vitamin A dimerization. Stargardt disease is an inherited form of macular degeneration with no FDA-approved treatment available to date.
29 sty 2024 · Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial. Alkeus Pharmaceuticals has revealed promising early results from its TEASE-3 clinical trial of the drug ALK-001.
8 gru 2021 · Professor Andrew Lotery has provided an update on the latest research into a potential treatment for Stargardt disease at our latest Virtual Clinic event. The research is looking into whether a drug called Remofuscin could be an effective treatment for Stargardt disease, preventing sight loss caused by the condition.
The purpose of this study is to determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in subjects with Stargardt disease (STGD).
28 lip 2023 · With stem cell therapy, the visual acuity improved significantly in 38 eyes out of 95 treated eyes. No tumor formation, teratoma formation, differentiation of stem cell into ectopic cells, or immune rejection of the transplanted tissue was found.
Stargardt macular dystrophy (Stargardt disease; STGD1; OMIM 248200) is the most prevalent inherited macular dystrophy. STGD1 is an autosomal recessive disorder caused by multiple pathogenic sequence variants in the large ABCA4 gene (OMIM 601691).
